Background We previously demonstrated very low levels of xenoreactive
natural antibodies in newborns, suggesting the possibility of prolonga
tion of xenograft survival in newborn recipients. We used a pig-to-new
born goat heterotopic cardiac xenograft model to examine our hypothesi
s that hyperacute rejection would be absent in newborn recipients and
that both humoral and cellular rejection would participate in the late
phase of discordant xenograft rejection. Methods and Results The seru
m of newborn goats was found to have very low titers of natural anti-p
ig antibodies. Newborn pig hearts were transplanted heterotopically in
to the neck of four unmanipulated newborn goats: none of these xenogra
fts underwent hyperacute rejection. Dilation of the xenografts and dec
reased contractility were observed 4 to 6 days after transplantation,
and the xenografts eventually ceased functioning between 6 and 8 days
after transplantation. Blood samples collected after transplantation d
emonstrated a dramatic increase in anti-pig xenoantibody titers and co
rrelated with histological studies demonstrating features consistent w
ith delayed humoral rejection, including reactive vascular endothelial
and perivascular stromal cells, marked capillary congestion, and inte
rstitial hemorrhages. Scant to diffuse perivascular and interstitial i
nfiltration of activated lymphoid cells occurred. Conclusions Our stud
y demonstrates that hyperacute rejection does not occur, allowing limi
ted prolongation of xenograft survival in a pig-to-newborn goat cardia
c xenograft model. We propose that this is attributable, at least in p
art, to the very low titers of natural antibodies in newborn recipient
s. Delayed xenograft rejection, however, remains an important problem
in these newborn recipients. This delayed xenograft rejection is likel
y the result of both humoral and cellular rejection mechanisms.